Bivariate analysis of basal serum anti-Müllerian hormone measurements and human blastocyst development after IVF

Reproductive Biology and Endocrinology

Volumn 9, Issue , 2011, Pages

  Sills, E Scott ^a,d   Collins, Gary S ^b   Brady, Adam C ^c   Walsh, David J ^d   Marron, Kevin D ^d   Peck, Alison C ^a   Walsh, Anthony P H ^d   Salem, Rifaat D ^a  

^a Pacific Reproductive Center   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Blastocyst transfer; Embryo development; IVF; Serum AMH

Indexed keywords

ESTRADIOL; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; BIVARIATE ANALYSIS; BLASTOCYST; CONTROLLED STUDY; CORRELATIONAL STUDY; EMBRYO; EMBRYO CULTURE; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; RETROSPECTIVE STUDY; BLOOD; CYTOLOGY; EMBRYO DEVELOPMENT; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSIOLOGY; PREGNANCY; PREGNANCY RATE;

ADULT; ANTI-MULLERIAN HORMONE; BLASTOCYST; EMBRYO CULTURE TECHNIQUES; EMBRYONIC DEVELOPMENT; FEMALE; FERTILIZATION IN VITRO; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES;

EID: 82455168241     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-9-153     Document Type: Article

References (30)

1. Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction 2002, 124:601-609. 10.1530/rep.0.1240601, 12416998.
2. di Clemente N, Josso N, Gouédard L, Belville C. Components of the anti-Müllerian hormone signaling pathway in gonads. Mol Cell Endocrinol 2003, 211:9-14. 10.1016/j.mce.2003.09.005, 14656470.
3. Pask AJ, Whitworth DJ, Mao CA, Wei KJ, Sankovic N, Graves JA, Shaw G, Renfree MB, Behringer RR. Marsupial anti-Mullerian hormone gene structure, regulatory elements, and expression. Biol Reprod 2004, 70:160-167.
4. van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, Fauser BJ, Themmen AP, te Velde ER. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005, 83:979-987. 10.1016/j.fertnstert.2004.11.029, 15820810.
5. La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod 2006, 21:3103-3107. 10.1093/humrep/del291, 16923748.
6. Liberty G, Ben-Chetrit A, Margalioth EJ, Hyman JH, Galoyan N, Eldar-Geva T. Does estrogen directly modulate anti-müllerian hormone secretion in women?. Fertil Steril 2010, 94:2253-2256. 10.1016/j.fertnstert.2010.01.018, 20356582.
7. Mohamed KA, Davies WA, Lashen H. Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate. Fertil Steril 2006, 86:1515-1517. 10.1016/j.fertnstert.2006.03.047, 16978621.
8. La Marca A, De Leo V, Giulini S, Orvieto R, Malmusi S, Giannella L, Volpe A. Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause. J Soc Gynecol Investig 2005, 12:545-548. 10.1016/j.jsgi.2005.06.001, 16046154.
9. Visser J. Role of anti-Müllerian hormone in follicle recruitment and maturation. J Gynecol Obstet Biol Reprod (Paris) 2006, 35(5 Pt 2):2S30-2S34.
10. Sills ES, Alper MM, Walsh AP. Ovarian reserve screening in infertility: practical applications and theoretical directions for research. Eur J Obstet Gynecol Reprod Biol 2009, 146:30-36. 10.1016/j.ejogrb.2009.05.008, 19487066.
11. Sills ES, Drews CD, Perloe M, Kaplan CR, Tucker MJ. Periovulatory serum human chorionic gonadotropin (hCG) concentrations following subcutaneous and intramuscular nonrecombinant hCG use during ovulation induction: a prospective, randomized trial. Fertil Steril 2001, 76:397-9. 10.1016/S0015-0282(01)01903-3, 11476796.
12. Walsh AP, Shkrobot LV, Coull GD, Peirce KL, Walsh DJ, Salma U, Sills ES. Blastocyst transfer for multiple prior IVF failure: a five year descriptive study. Ir Med J 2009, 102:282-285.
13. Riggs R, Kimble T, Oehninger S, Bocca S, Zhao Y, Leader B, Stadtmauer L. Anti-Müllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation. Fertil Steril 2011, 95:410-412. 10.1016/j.fertnstert.2010.07.1042, 20736131.
14. Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod 2006, 21:2022-6. 10.1093/humrep/del127, 16679324.
15. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996, 81:571-576. 10.1210/jc.81.2.571, 8636269.
16. Guibourdenche J, Lucidarme N, Chevenne D, Rigal O, Nicolas M, Luton D, Léger J, Porquet D, Noël M. Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Mol Cell Endocrinol 2003, 211:55-63. 10.1016/j.mce.2003.09.011, 14656477.
17. van Rooij IA, Tonkelaar I, Broekmans FJ, Looman CW, Scheffer GJ, de Jong FH, Themmen AP, te Velde ER. Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004, 11:601-606. 10.1097/01.GME.0000123642.76105.6E, 15545787.
18. Rigon C, Andrisani A, Forzan M, D'Antona D, Bruson A, Cosmi E, Ambrosini G, Tiboni GM, Clementi M. Association study of AMH and AMHRII polymorphisms with unexplained infertility. Fertil Steril 2010, 94:1244-1248. 10.1016/j.fertnstert.2009.05.025, 19539910.
19. Nicopoullos JD, Abdalla H. Poor response cycles: when should we cancel? Comparison of outcome between egg collection, intrauterine insemination conversion, and follow-up cycles after abandonment. Fertil Steril 2011, 95:68-71. 10.1016/j.fertnstert.2010.05.030, 20646690.
20. Alper MM, Smith LP, Sills ES. Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management. J Exp Clin Assist Reprod 2009, 6:3. 2868304, 20485578.
21. Nakhuda GS, Douglas NC, Thornton MH, Guarnaccia MM, Lobo R, Sauer MV. Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors. Reprod Biomed Online 2010, 20:42-47. 10.1016/j.rbmo.2009.10.009, 20158986.
22. Li HWR, Yeung WSB, Lau EYL, Ho PCH, Ng EHY. Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination. Fertil Steril 2010, 94:2177-2181. 10.1016/j.fertnstert.2009.12.059, 20171627.
23. Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY. Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction. Hum Reprod 2010, 25:2597-2604. 10.1093/humrep/deq204, 20729237.
24. Lambalk CB, van Disseldorp J, de Koning CH, Broekmans FJ. Testing ovarian reserve to predict age at menopause. Maturitas 2009, 63:280-291. 10.1016/j.maturitas.2009.06.007, 19631481.
25. Tehrani FR, Solaymani-Dodaran M, Azizi F. A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause 2009, 16:797-802. 10.1097/GME.0b013e318193e95d, 19225427.
26. Shebl O, Ebner T, Sommergruber M, Sir A, Tews G. Anti muellerian hormone serum levels in women with endometriosis: a case-control study. Gynecol Endocrinol 2009, 25:713-716. 10.3109/09513590903159615, 19903049.
27. Desforges-Bullet V, Gallo C, Lefebvre C, Pigny P, Dewailly D, Catteau-Jonard S. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization. Fertil Steril 2010, 94:198-204. 10.1016/j.fertnstert.2009.03.004, 19361798.
28. Wu CH, Chen YC, Wu HH, Yang JG, Chang YJ, Tsai HD. Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients. J Assist Reprod Genet 2009, 26:383-389. 10.1007/s10815-009-9332-8, 2758947, 19768530.
29. Majumder K, Gelbaya TA, Laing I, Nardo LG. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Eur J Obstet Gynecol Reprod Biol 2010, 150:166-170. 10.1016/j.ejogrb.2010.02.029, 20223579.
30. La Marca A, Broekmans FJ, Volpe A, Fauser BC, Macklon NS, . ESHRE Special Interest Group for Reproductive Endocrinology--AMH Round Table Anti-Mullerian hormone (AMH): what do we still need to know?. Hum Reprod 2009, 24:2264-2275. 10.1093/humrep/dep210, 19520713, ESHRE Special Interest Group for Reproductive Endocrinology--AMH Round Table.